Call Us for Support
+91 9654860915
Google Reviews
4.8
Call Us for Support
+91 9654860915
Sourced directly from the authorized manufacturer network to ensure authenticity and quality.
Ready to proceed? Start a request for Simenafil on our secure patient portal to submit your prescription, upload documents and track your approval status.
Supplied with complete CDSCO-approved import and customs documentation, including Form 12A & 12B, CDEC, GST Bill of Entry, Commercial Invoice, and Packing List.
Manufacturer / Innovator:
China
Regulatory Approval:
Your Trustworthy Partner For Named Patient Program
Over a decade of trusted expertise in Named Patient Access to innovative and life-saving medicines.
100% CDSCO-compliant processes ensuring safe, ethical, and responsible medicine access.
Medicines sourced from authorized manufacturers with full batch traceability.
EU-GDP compliant warehousing for secure, quality-controlled global distribution.
Temperature-controlled logistics ensuring safe, reliable, and timely medicine delivery.
Simenafil is a tablet for erectile dysfunction (ED), the ongoing difficulty in getting or keeping an erection firm enough for sex. It was developed in China by Vigonvita Life Sciences together with the Shanghai Institute of Materia Medica of the Chinese Academy of Sciences, and was known in research as TPN171. In China it is sold as 昂伟达® (simenafil hydrochloride tablets, 盐酸司美那非片).
China's National Medical Products Administration (NMPA) approved it on 8 July 2025 for:
The company reports an earlier approval in Uzbekistan in 2022, where it is sold as Onvita®. It is a prescription medicine listed in our other therapeutic areas section, and it should be prescribed by a urologist, andrologist or physician after a proper check-up.
During sexual arousal the body releases a messenger called cGMP, which relaxes the blood vessels in the penis so blood can flow in. An enzyme called PDE5 breaks cGMP down. Simenafil is a highly selective PDE5 inhibitor: it slows that breakdown, so the natural response to arousal lasts longer. It does not cause an erection without sexual stimulation. According to the company, it acts on PDE5 far more than on related enzymes linked with eye and muscle side effects.
The phase 3 trial, published in The Journal of Sexual Medicine in 2025, included 765 men aged 18 to 75 in China, most with moderate to severe ED. They took 2.5 mg, 5 mg or 10 mg when needed, or a placebo, for 12 weeks. On the standard erectile function score (IIEF-EF, where 26 or more counts as normal), scores rose by 12.3, 12.3 and 12.7 points with the three doses, against 9.6 points with placebo (all P < .001). The company reports that average scores reached 25.6 to 26.1, close to the normal range. 92.3% of the men completed the study.
Your doctor will confirm the dose and how often it can be taken from the Chinese prescribing information.
This information is not a treatment plan. For personalized medical advice, consult your doctor and refer to the full prescribing information.
Nitrate heart medicines: as a group, PDE5 inhibitors are not used together with nitrates, because the combination can cause a sudden, dangerous drop in blood pressure. Tell your doctor if you take or carry any nitrate medicine for chest pain, and ask about any heart condition before starting.
ED can be an early sign of heart disease, diabetes or hormone problems, so a check-up before treatment is worthwhile. This medicine is for adult men only.
Step 1 – Search & request your medicine: The patient or treating doctor submits a request with basic details to initiate the access process.
Step 2 – Verification & eligibility review: The team verifies availability and reviews eligibility against regulatory and clinical requirements to ensure a compliant pathway.
Step 3 – Receive quote & delivery timeline: A transparent quotation is shared, covering medicine cost, logistics, and a clear delivery timeline.
Step 4 – Regulatory approval process: Assistance is provided to secure the approvals and documentation required for legal cross-border access.
Step 5 – Temperature-controlled import & handling: The medicine is sourced and transported under strict GDP-compliant conditions to maintain product integrity.
Step 6 – Secure delivery: The medicine is delivered to the patient or treating hospital, with updates provided at each stage.
Note: From request to delivery, every step is designed to ensure your treatment reaches you safely, compliantly, and without unnecessary delays.
The tablets can be imported only in the patient's name, in line with India's import regulations for unapproved medicines. You will need:
Once we have received and checked a valid prescription and, where needed, an import permit.
No. It has no CDSCO approval and is not sold in Indian pharmacies. It is approved in China, and the company reports approval in Uzbekistan; the US FDA and European Medicines Agency have not approved it.
Patients can still get it legally through the Named Patient Program (NPP), which allows a medicine not registered in India to be imported for one specific patient on a prescription. For men with Peyronie's disease, a condition that causes a curved erection, see our page on Xiaflex.
It can be made available to patients, doctors, and hospitals across major cities in India, including Gurgaon, Delhi, Bangalore, Mumbai, Navi Mumbai, Thane, Hyderabad, Mysore, Kerala, Chennai, Coimbatore, Madurai, Kolkata, Ahmedabad, Surat, Vadodara, Pune, Nagpur, Nashik, Jaipur, Udaipur, Lucknow, Kanpur, Gorakhpur, Chandigarh, Mohali, Faridabad, Noida, Ghaziabad, Kochi, Trivandrum, Kozhikode, Thrissur, Kannur, Mangalore, Bhubaneswar, Patna, Ranchi, Raipur, Guwahati, Visakhapatnam, Vijayawada, Goa, Jammu, Srinagar, Dehradun, Bhopal, Indore, Ludhiana, Amritsar, and others — and can facilitate delivery to the patient's treating hospital. Orders are confirmed only after receipt of a valid doctor's prescription and an import permit, where applicable.
NamedPatientProgram.com (NPP) sources this medicine through the manufacturer's authorised supply channels in China and arranges supply to patients and doctors under applicable legal provisions. The tablets are stored as directed on the pack and travel in their sealed original boxes under temperature-controlled shipping, in plain, discreet packaging. In China the 5 mg strength comes in boxes of 7 tablets, the 2.5 mg in boxes of 2 and the 10 mg as a single tablet. All prescriptions are dispensed and checked by registered pharmacists and dispatched from New Delhi, India, after legal requirements are fulfilled.
For the current cost in India and availability, contact NPP via WhatsApp at +91 98104 69557 | Toll-Free: 1800-1200-365 or email info@namedpatientprogram.com.
Patients across India can access this medicine through regulated import pathways, with discreet delivery arranged to the patient or clinic on a valid doctor's prescription.
Urology and andrology clinics in Delhi can request the tablets for a named patient, and our New Delhi dispatch point keeps delivery quick.
Patients in Mumbai can have the tablets delivered privately to their home once the prescription is checked.
Doctors in Bangalore can share the prescription with us, and the quote is sent before anything is ordered.
Patients across Chennai and Tamil Nadu can use the same documented import route, with updates at every step.
We deliver in discreet packaging to the address the patient chooses.
Patients from Kolkata and the eastern states can receive the tablets without needing to travel.
Andrologists in Pune can coordinate access for patients who need this specific medicine.
The treating doctor can send us the prescription and medical summary to begin the import.
Patients in Rajasthan can have the tablets delivered home, as long as the import is in their own name.
Serves patients from Punjab, Haryana and Himachal Pradesh, with delivery to home or clinic.
We coordinate delivery for patients treated at urology clinics across Uttar Pradesh.
Patients across Kerala can receive the tablets at home in Kochi and nearby cities.
Access can also be coordinated for patients in other Indian cities, subject to a valid prescription and regulatory requirements.
Written By
Nitin GoswamiDeputy Manager – Content & Social Media, Ikris Pharma Network
Sources: NMPA • CDSCO
Last Updated: 19 October 2026
Our specialists are here to guide you through every step of the medicine access process.
Mail Us At:
info@namedpatientprogram.comContact Us:
+91 9654860915Send us a message
